Renaissance Technologies's BHC Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 1.43 M shares of Bausch Health Companies Inc. (BHC) worth $9.95 M, representing 0.02% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in BHC, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2019, adding 7.43 M shares. Largest reduction occurred in Q1 2018, reducing 5.68 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Bausch Health Companies (BHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bausch Health Companies (BHC) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +247,519 | Add 20.89% | 1.43 M | $6.95 |
| Q3 2025 | +423,689 | Add 55.68% | 1.18 M | $6.45 |
| Q2 2025 | -148,589 | Reduce 16.34% | 760,983 | $6.66 |
| Q1 2025 | +414,400 | Add 83.69% | 909,572 | $6.47 |
| Q4 2024 | +468,572 | Add 1761.55% | 495,172 | $8.06 |
| Q3 2024 | +26,600 | New Buy | 26,600 | $8.16 |
| Q2 2024 | -15,600 | Sold Out | 0 | $0.00 |
| Q1 2024 | -249,689 | Reduce 94.12% | 15,600 | $10.58 |
| Q4 2023 | +265,289 | New Buy | 265,289 | $8.02 |
| Q2 2023 | -1.14 M | Sold Out | 0 | $0.00 |
| Q1 2023 | +1.14 M | New Buy | 1.14 M | $0.01 |
| Q3 2022 | -544,043 | Sold Out | 0 | $0.00 |
| Q2 2022 | -609,746 | Reduce 52.85% | 544,043 | $8.36 |
| Q1 2022 | +1.04 M | Add 903.29% | 1.15 M | $22.86 |
| Q4 2021 | +91,700 | Add 393.56% | 115,000 | $27.61 |
| Q3 2021 | -698,089 | Reduce 96.77% | 23,300 | $27.90 |
| Q2 2021 | -7,971 | Reduce 1.09% | 721,389 | $29.32 |
| Q1 2021 | -1.26 M | Reduce 63.35% | 729,360 | $31.74 |
| Q4 2020 | -1.66 M | Reduce 45.43% | 1.99 M | $20.78 |
| Q3 2020 | -4.63 M | Reduce 55.96% | 3.65 M | $15.54 |
| Q2 2020 | -5.12 M | Reduce 38.21% | 8.28 M | $18.29 |
| Q1 2020 | +910,550 | Add 7.29% | 13.4 M | $15.50 |
| Q4 2019 | +7.43 M | Add 146.76% | 12.49 M | $29.92 |
| Q3 2019 | +2.03 M | Add 66.68% | 5.06 M | $21.85 |
| Q2 2019 | +272,000 | Add 9.84% | 3.04 M | $25.22 |
| Q1 2019 | +631,500 | Add 29.60% | 2.77 M | $24.70 |
| Q4 2018 | +230,918 | Add 12.14% | 2.13 M | $18.47 |
| Q3 2018 | -2.19 M | Reduce 53.52% | 1.9 M | $25.67 |
| Q2 2018 | -882,100 | Reduce 17.73% | 4.09 M | $23.24 |
| Q1 2018 | -5.68 M | Reduce 53.29% | 4.98 M | $15.92 |
| Q4 2017 | +5.87 M | Add 122.80% | 10.65 M | $20.78 |
| Q3 2017 | +2.38 M | Add 98.97% | 4.78 M | $14.33 |
| Q2 2017 | +2.4 M | New Buy | 2.4 M | $17.30 |
| Q1 2017 | -2.91 M | Sold Out | 0 | $0.00 |
| Q4 2016 | +2.48 M | Add 573.56% | 2.91 M | $14.52 |
| Q3 2016 | +320,600 | Add 286.53% | 432,489 | $24.55 |
| Q2 2016 | +111,889 | New Buy | 111,889 | $20.14 |
| Q3 2015 | -107,789 | Sold Out | 0 | $0.00 |
| Q2 2015 | -368,048 | Reduce 77.35% | 107,789 | $222.12 |
| Q1 2015 | +436,848 | Add 1120.44% | 475,837 | $198.52 |
| Q4 2014 | +38,989 | New Buy | 38,989 | $143.12 |
| Q2 2014 | -47,189 | Sold Out | 0 | $0.00 |
| Q1 2014 | -317,000 | Reduce 87.04% | 47,189 | $131.77 |
| Q4 2013 | +364,189 | New Buy | 364,189 | $117.40 |
Renaissance Technologies's Bausch Health Companies Investment FAQs
Renaissance Technologies first purchased Bausch Health Companies Inc. (BHC) in Q4 2013, acquiring 364,189 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Bausch Health Companies Inc. (BHC) for 44 quarters since Q4 2013.
Renaissance Technologies's largest addition to Bausch Health Companies Inc. (BHC) was in Q4 2019, adding 12,491,799 shares worth $373.77 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 1,432,191 shares of Bausch Health Companies Inc. (BHC), valued at approximately $9.95 M.
As of the Q4 2025 filing, Bausch Health Companies Inc. (BHC) represents approximately 0.02% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Bausch Health Companies Inc. (BHC) was 13,402,349 shares, as reported at the end of Q1 2020.